Skip to Main Content

Paper Details

Multivalent <i>in vivo</i> delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escape.
Mol Ther Oncolytics
6
2023
Author NameAffiliation
David B WeinerPerelman School of Medicine, The University of Pennsylvania
David B WeinerThe Wistar Institute
  • 1 - 2

Datasets

Release 1.2